Research-grade GHK-Cu refers to the isolated, high-purity compound used in laboratory settings
BPC-157 is not designated for medical, diagnostic, or therapeutic applications
Neuropediatrics 44:218221 Celestino-Soper PB, Violante S, Crawford EL, Luo R, Lionel AC, Delaby E, Cai G, Sadikovic B, Lee K, Lo C, Gao K, Person RE, Moss TJ, German JR, Huang N, Shinawi M, Treadwell-Deering D, Szatmari P, Roberts W, Fernandez B, Schroer RJ, Stevenson RE, Buxbaum JD, Betancur C, Scherer SW, Sanders SJ, Geschwind DH, Sutcliffe JS, Hurles ME, Wanders RJ, Shaw CA, Leal SM, Cook EH Jr, Goin-Kochel RP, Vaz FM, Beaudet AL (2012) A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism
Refractory SLE patients respond to the proteasome inhibitor bortezomib
those observed in the PIONEER-1 trial of oral semaglutide (Rybelsus, Novo Nordisk) and the SUSTAIN-1 trial of injectable semaglutide (Ozempic, Novo Nordisk)
Di Rienzo T